Abstract: A biocompatible material for bone repair is described. The bone repair composition includes a mixture of a type I collagen, a type I collagen-glycosaminoglycan coprecipitate, tricalcium phosphate; and bioactive glass. Methods of using the composition for bone repair, and a kit for the bone repair composition are also described.

Abstract: A composition includes bone and collagen, wherein the collagen has been acid treated, and cross-linked via dehydrothermal treatment or by a cross-linking agent (e.g., a citric acid derivative) under a compressive force of at least approximately 40 MPa.

Abstract: Purifying human derived collagen from human tissue includes treating harvested human tissue with an enzyme to form a collagen product, deactivating the enzyme with a non-alkaline enzyme deactivation solution, and collecting the collagen product resulting from the enzyme treatment, where the collected collagen product includes a preserved amount of its natural collagen constituents. Various medical implants can be formed using the isolated, enzymatically-treated human derived collagen having an amount of its natural collagen constituents preserved, and may include implantable sponges, patches, tubes, structural supports and coatings, and which may be used for repair, barrier, support and/or stabilization purposes.

Abstract: Compositions and methods for treating and healing injured soft tissues such as tendons and ligaments are provided. The composition may be a wrap comprising human collagen in the form of a sheet. The human collagen has been processed so that is retains proteins that are associated with it in its natural state. The sheet may optionally be coated on one or more sides with one or more of additional human collagen, therapeutic agents, additional soft tissue growth factors or hydroxyapatite.

Abstract: Compositions and methods for treating and healing injured soft tissues such as tendons and ligaments are provided. The composition may be a wrap comprising human collagen in the form of a sheet. The human collagen has been processed so that is retains proteins that are associated with it in its natural state. The sheet may optionally be coated on one or more sides with one or more of additional human collagen, therapeutic agents, additional soft tissue growth factors or hydroxyapatite.

Abstract: A composition includes bone and collagen, wherein the collagen has been acid treated, and cross-linked via dehydrothermal treatment or by a cross-linking agent (e.g., a citric acid derivative) under a compressive force of at least approximately 40 MPa.

Abstract: In various embodiments, a collagen product is provided that is derived from an animal, the collagen product comprises precipitated collagen that is substantially pure. In various embodiments, the collagen is obtained from a marine animal and does not contain prions or viruses. In various embodiments, the collagen can be made or incorporated into collagen films, collagen membranes, cosmetic collagen masks, collagen sponges, gelatin, hemostasis sponges, lyophilized foams, collagen injections, artificial skins and dura, bones, cartilage, screws, shafts, stems, or tube guides.

Abstract: Medical implants and methods for forming a medical implant blends a dispersion of human collagen fibers and/or threads and optionally a volume between about 2 to about 15% of an alcohol and forms medical implants by removing a liquid component of the collagen dispersion. Medical implants formed include collagen films, coatings, threads, patches, tubes, plugs, scaffolds, injectable collagen, and collagen for in vitro applications.

Abstract: Purifying human derived collagen from human tissue includes treating harvested human tissue with an enzyme to form a collagen product, deactivating the enzyme with a non-alkaline enzyme deactivation solution, and collecting the collagen product resulting from the enzyme treatment, where the collected collagen product includes a preserved amount of its natural collagen constituents. Various medical implants can be formed using the isolated, enzymatically-treated human derived collagen having an amount of its natural collagen constituents preserved, and may include implantable sponges, patches, tubes, structural supports and coatings, and which may be used for repair, barrier, support and/or stabilization purposes.

Abstract: The present invention provides methods and compositions involving resorbable hemostatic agents that have the essential absence of microfibrillar collagen. Resorbable hemostatic agents of the present invention comprise polyethylene glycol, which controls bleeding in tissue and does not delay or interfere with healing. The resorbable hemostatic agents of the present invention are biodegradable and biocompatible agents that effectively control bleeding in bone and other tissue without interfering with the subsequent healing of the tissue.

Abstract: The present invention provides methods and compositions involving resorbable hemostatic agents that have the essential absence of microfibrillar collagen. Resorbable hemostatic agents of the present invention comprise polyethylene glycol, which controls bleeding in tissue and does not delay or interfere with healing. The resorbable hemostatic agents of the present invention are biodegradable and biocompatible agents that effectively control bleeding in bone and other tissue without interfering with the subsequent healing of the tissue.

Abstract: Absorbent products having integral belt means for retaining the absorbent product in a position to absorb body fluids are disclosed. In a preferred embodiment, a napkin is provided wherein straps are cut from the material of the napkin. These straps are then tied around the body of the user when the napkin is applied. The straps are flexible enough to allow them easily to be tied to each other on the side. The straps may or may not be retained by the waistband of an undergarment. Alternatively, a second embodiment is provided wherein long flap-like straps extend longitudinally away from the transverse ends of the absorbent product. These straps are then engaged by the elastic waistband on an undergarment, to retain the napkin in place. Methods of manufacturing absorbent products are also disclosed.

Abstract: This invention relates to polymer film or foam coatings for the covers of absorbent articles. More particularly, this invention relates to absorbent products and processes for making in situ foamed polymer coatings which give an opaque, soft, dry and clean-appearing water-permeable cover to absorbent products such as sanitary napkins, diapers and the like.

Abstract: This invention relates to polymer film or foam coatings for the covers of absorbent articles. More particularly, this invention relates to absorbent products and processes for making in situ foamed polymer coatings which give an opaque, soft, dry and clean-appearing water-permeable cover to absorbent products such as sanitary napkins, diapers and the like.

Abstract: A method of making an absorbent product in which pressure sensitive adhesive is used to attach the product to a user's undergarment. The product does not require release paper to protect the adhesive from unintended contact prior to use. The product is made by forming depressions in a fluid impervious barrier so as to create raised areas in the barrier that protect the adhesive. The depressions may be formed in the garment facing surface of the barrier and the adhesive applied within the depressions so that the raised areas adjacent the depressions protect the adhesive. Alternatively, the depressions may be formed in the surface of the barrier opposite the garment facing surface so as to create raised areas in the garment facing surface and the adhesive applied adjacent the raised areas.

Abstract: A continuous process for manufacturing absorbent pads is disclosed which comprises providing a fibrous web material and applying a fluid absorbent cover and a fluid impermeable barrier layer thereto in situ. In preferred embodiments, the pads are securable to fluid-protected surfaces by means of an adhesive on the barrier layer's outer surface.

Abstract: Adhesive bandages comprising a blister pad and adjacent adhesive-coated areas are prepared from heat-fusible bandage materials, preferably a nonwoven batt material, by applying the pad material to a base material and heat-welding around the perimeter of the pad to totally enclose the interior thereof. The portions of the base material extending from the pad area are compacted under heat and pressure to provide a surface suitable for a coating with adhesive. A medicated gel or other therapeutic material may be included within the confines of the pad area to provide a medicated blister bandage.

Abstract: An adhesive bandage and integral wrapper therefor is constructed of a continuous length of bulky, nonwoven bandage and wrapper material which is preferably a nonwoven fabric batt constructed at least in part of heat-fusible fibers. The bandage pad is formed by a Z-fold in the bandage portion of the material. The adhesive wing portions of the bandage are compacted and fused prior to the application of a pressure-sensitive adhesive. The wrapper portion of the product may be entirely nonwoven fabric compacted and heat-fused and coated with an adhesive release surface, or may be formed in part of polyethylene or similar film. The wrapper material is folded around the bandage and sealed on three edges to totally enclose the bandage.

Abstract: A packaged adhesive bandage comprising a bandage backing strip having an adhesive coating and a wound covering pad on one surface thereof contained in a sealed envelope with the side edges of the backing strip laminated and sealed between the panels of the envelope. The packaged bandage is produced by a continuous process wherein a length of wrapper material is folded to enclose a length of bandage material and individual bandages are cut transversely from the folded material with simultaneous sealing of the cut edges.

Abstract: An adhesive bandage and integral wrapper therefor is constructed of a continuous length of bulky, nonwoven bandage and wrapper material which is preferably a nonwoven fabric batt constructed at least in part of heat-fusible fibers. The bandage pad is formed by a Z-fold in the bandage portion of the material. The adhesive wing portions of the bandage are compacted and fused prior to the application of a pressure-sensitive adhesive. The wrapper portion of the product may be entirely nonwoven fabric compacted and heat-fused and coated with an adhesive release surface, or may be formed in part of polyethylene or similar film. The wrapper material is folded around the bandage and sealed on three edges to totally enclose the bandage.